1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow BLATAM: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy intravesical Chemotherapy docetaxel/gemcitabine - Non Muscle Invasive Bladder Cancer | Phase 2 | Recruiting | BLATAM | 37 | 2026-05-21 | 2026-05-28 |
Non-Muscle Invasive Bladder Neoplasms (1)
Gemcitabine (1)
Argentina (1)